Akebia Therapeutics
AKBA
AKBA
169 hedge funds and large institutions have $694M invested in Akebia Therapeutics in 2019 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 51 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.44% more ownership
Funds ownership: 69.91% → 72.35% (+2.4%)
2% more funds holding
Funds holding: 166 → 169 (+3)
8% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 51
Holders
169
Holding in Top 10
2
Calls
$3.23M
Puts
$1.52M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$9.35M | |
| 3 | +$7.34M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.09M |
| 5 |
TA
Teachers Advisors
New York
|
+$5.95M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$4.07M | |
| 3 | -$3.81M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.79M |
| 5 |
Citigroup
New York
|
-$2.11M |